NCT03753516

Brief Summary

The purpose of this study is to learn about the effect of different vaginal cuff closure techniques on pelvic support after laparoscopic hysterectomy and robotic assisted laparoscopic hysterectomy for benign gynecologic conditions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2017

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 20, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 27, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

3.5 years

First QC Date

November 20, 2018

Last Update Submit

October 8, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pelvic Organ Prolapse - Quantification Point C

    The Pelvic Organ Prolapse - Quantification system is a validated way to measure pelvic organ prolapse. The investigators will measure this post op at 6-8 weeks to see if prolapse is better using one method vs the other.

    6-8 weeks post op

  • Pelvic Organ Prolapse - Quantification Point C

    The Pelvic Organ Prolapse - Quantification system is a validated way to measure pelvic organ prolapse. The investigators will measure this post op at 1 year to see if prolapse is better using one method vs the other.

    1 year post op

Secondary Outcomes (4)

  • Vaginal Cuff Dehiscence

    1 year

  • Vaginal Cuff Abscess

    1 year

  • Vaginal Cuff Cellulitis

    1 year

  • Vaginal Cuff bleeding

    1 year

Study Arms (2)

Laparoscopic - Vaginal Cuff Closure

ACTIVE COMPARATOR
Procedure: Laparoscopic - Vaginal Cuff Closure

Vaginal - Vaginal Cuff Closure

ACTIVE COMPARATOR
Procedure: Vaginal- Vaginal Cuff Closure

Interventions

All participants are scheduled for either laparoscopic or robotic assisted total hysterectomy. At the end of the hysterectomy the vaginal cuff is closed. In this arm the vaginal cuff will be close laparoscopically using an 0-Barbed suture.

Laparoscopic - Vaginal Cuff Closure

All participants are scheduled for either laparoscopic or robotic assisted total hysterectomy. At the end of the hysterectomy the vaginal cuff is closed. In this arm the vaginal cuff will be close vaginally using an 0-Vicryl suture in a vertical fashion.

Vaginal - Vaginal Cuff Closure

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women over 18 years of age undergoing total laparoscopic hysterectomy and robotic assisted total laparoscopic hysterectomy for benign disease.
  • Subjects must be able to self-consent.
  • Department of Defense beneficiary

You may not qualify if:

  • Patients will be excluded if they undergo a concurrent procedure for prolapse.
  • If the indication for the procedure is a malignancy.
  • Those that plan to leave the area in less than 1 year will not be included.
  • Pop-Q Point C of \>-4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Walter Reed National Military Medical Center

Bethesda, Maryland, 20889, United States

Location

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2018

First Posted

November 27, 2018

Study Start

July 1, 2017

Primary Completion

December 30, 2020

Study Completion

December 30, 2020

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations